Jordi Monés
About
In The Last Decade
Jordi Monés
71 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Ophthalmology 2.9k
- Radiology, Nuclear Medicine and Imaging 2.2k
- Molecular Biology 645
- Epidemiology 389
- Immunology 144
Countries citing papers authored by Jordi Monés
This map shows the geographic impact of Jordi Monés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Monés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Monés more than expected).
Fields of papers citing papers by Jordi Monés
This network shows the impact of papers produced by Jordi Monés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Monés. The network helps show where Jordi Monés may publish in the future.
Co-authorship network of co-authors of Jordi Monés
This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Monés. A scholar is included among the top collaborators of Jordi Monés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Monés. Jordi Monés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 24 | |
| 3 | Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: CAM Report 5. | 6 |
| 4 | 27 | |
| 5 | Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab breakdown → | 238 |
| 6 | C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration breakdown → | 307 |
| 7 | 75 | |
| 8 | 50 | |
| 9 | 2 | |
| 10 | 65 | |
| 11 | 11 | |
| 12 | 14 | |
| 13 | 75 | |
| 14 | 114 | |
| 15 | 200 | |
| 16 | 2 | |
| 17 | Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) breakdown → | 478 |
| 18 | 7 | |
| 19 | 57 | |
| 20 | Humanistic Burden and Health Resource Utilization Among Neovascular Age–Related Macular Degeneration (AMD) Patients: Results from a Multi–Country Cross–Sectional Study | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.